問卷

TPIDB > Principal Investigator

Principal Investigator


Chi Mei Medical Center (在職)

Division of Rheumatology

Division of General Internal Medicine

更新時間:2023-09-19

陳宏安
  • Principal Investigator
  • Clinical Trial Experience (year)

篩選

List

41Cases

2017-07-01 - 2022-01-01

Phase III

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, 24-Week Study Followed by Long-Term Treatment for Evaluation of Efficacy and Safety of Baricitinib in Patients with Active Psoriatic Arthritis
  • Condition/Disease

    Psoriatic Arthritis

  • Test Drug

    Baricitinib (LY3009104)

Participate Sites
9Sites

Not yet recruiting8Sites

1 2 3 4 5